Maternal Folate Nutrition Programs Adult Hematopoietic Stem Cell Function Through Mitochondrial Remodeling
Folic acid fortification for the prevention of neural tube defects has been a cornerstone of public health policy for nearly three decades, but its broader consequences for other developing organ systems, particularly the hematopoietic system, are poorly studied. Hematopoietic stem cell (HSC) emergence overlaps developmentally with neural tube closure, and folate-dependent one-carbon metabolism is critical for nucleotide synthesis, cellular methylation, and redox balance, positioning folate as a candidate regulator of HSC programming. Using dietary models of maternal folate deficiency or supplementation in mice, we demonstrate that maternal folate acts as a dose-dependent developmental tuner of hematopoiesis, programming adult offspring HSC function through divergent mitochondrial and chromatin states. Maternal folate deficiency impaired adult HSC self-renewal, associated with mitochondrial defects, disrupted cristae, elevated proteotoxic stress and a stress-adapted chromatin landscape. In contrast, maternal folate supplementation enhanced HSC self-renewal accompanied by improved mitochondrial quality control and CDC42-associated organelle remodeling, and established chromatin states permissive for stem cell maintenance. Fetal HSC metabolomics identified shifts in one-carbon intermediates, pyruvate and lipid pools, suggesting that divergent fetal metabolic states provide substrate-level inputs that drive persistent and opposing chromatin programs in offspring HSCs. Our findings establish maternal folate availability as an unappreciated regulator of lifelong hematopoietic output demonstrating that a single maternal micronutrient, folate, is sufficient to program adult HSC function and regenerative capacity through persistent metabolic and mitochondrial programming.
Authors
- Ava Niazi (ORCID: https://orcid.org/0000-0002-3075-3279)
- Sajesan Aryal (ORCID: https://orcid.org/0000-0001-6154-0586)
- Martha S. Field (ORCID: https://orcid.org/0000-0001-7547-5180)
- Anna E. Beaudin (ORCID: https://orcid.org/0000-0002-8580-8660)
- Sweta B. Patel (ORCID: https://orcid.org/0000-0001-7082-7204)
- Robert S. Welner (ORCID: https://orcid.org/0000-0003-2498-9469)
- Travis G. Nemkov (ORCID: https://orcid.org/0000-0001-8566-7119)
- Angelo D’Alessandro (ORCID: https://orcid.org/0000-0002-2258-6490)
- Robert A. J. Signer (ORCID: https://orcid.org/0000-0003-3286-1334)
- Luisa F. Castillo (ORCID: https://orcid.org/0000-0002-0069-0414)
- Rui Lu (ORCID: https://orcid.org/0000-0003-1593-2612)
- Anton Classen (ORCID: https://orcid.org/0009-0005-5595-1836)
- Alana Marie Franceski (ORCID: https://orcid.org/0000-0002-1895-5337)
- Noah Huerta
- Fanny Zhou
- Victoria Chiou
- Brittant Curtiss
- Brian P Krum
Institutions
- Cornell University (US)
- University of Utah (US)
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-10-28
- DOI
- https://doi.org/10.64898/2026.10.26.761955
- Primary Topic
- Folate and B Vitamins Research
- Type
- preprint
Funders
- Huntsman Cancer Institute
- National Institutes of Health
- University of California, San Diego
- National Institute on Aging
- National Heart, Lung, and Blood Institute
- National Cancer Institute
- National Institute on Deafness and Other Communication Disorders
- National Institute of Diabetes and Digestive and Kidney Diseases